Bold Vision.
Innovation at its best.

ProPhase Labs is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers.

We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives.  We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach.







Press Releases

See our latest innovations and breaking news

Apr 10 2024 8:00AM ET

ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024

Read More

Apr 01 2024 9:00PM ET

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read More

Mar 15 2024 8:00AM ET

ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives

Read More
Investor Relations

Get In Touch

We care about your questions and will be in touch usually within 24 hours

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Dev Tool:

Request: None
Matched Rewrite Rule: None
Matched Rewrite Query: None
Loaded Template: front-page.php